{"filing":{"accession_number":"0001493152-26-036032","cik":"0001533743","ticker":"PCSA","company_name":"Processa Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-07-30","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm"},"events":[{"id":23755,"run_id":21486,"accession_number":"0001493152-26-036032","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses results of the 2026 Annual Meeting of Shareholders held on July 30, 2026, with detailed voting outcomes on four proposals: election of six directors, amendment to the 2019 Omnibus Incentive Plan to increase shares by 200,000, ratification of Cherry Bekaert as independent auditor, and an advisory vote on named executive officer compensation. Item 5.07 explicitly presents the vote tallies for each proposal, which is the core disclosure of shareholder voting results.","company_name":"Processa Pharmaceuticals, Inc.","ticker":"PCSA","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":24075,"accession_number":"0001493152-26-036032","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses results of the 2026 Annual Meeting of Shareholders held on July 30, 2026, with detailed voting outcomes on four proposals: election of six directors, amendment to the 2019 Omnibus Incentive Plan to increase shares by 200,000, ratification of Cherry Bekaert as independent auditor, and an advisory vote on named executive officer compensation. Item 5.07 explicitly presents the vote tallies for each proposal, which is the core disclosure of shareholder voting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:36:13.823786+00:00","company_name":"Processa Pharmaceuticals, Inc.","ticker":"PCSA","filing_date":"2026-08-04"}]}